Q3 report due on Monday, 17 October Transportation prices coming down, input costs still high 10x ...
Net profit guidance downgraded to DKK 500m-600m Bond portfolio suffering from increasing interest r...
Huvudverksamheterna tuffar på och bolaget presterar i höjd med omsättningsmålet.
Maven Wireless har på det senaste kommunicerat fem nya orders, i Polen, Nederländerna, Turkiet, Fili...
We attended Rovio’s Q3 mid-quarter meeting for sell-side analysts today, which was hosted by IR Timo...
Redeye updates its estimates for the Q3 report with lower sales and margin compared to previous esti...
Redeye comments on RLS’s directed issue of new shares to Zebra holdings and Investments Limited.
Cantargia announced the first patient treatment under the extension arm of its Phase Ib clinical tri...
Redeye leaves a comment following Lipum’s announcement yesterday evening of a directed share issue o...
Eevia Health offer organic plant extracts for food nutraceuticals, drinks, and cosmetics under diffe...
Redeye notes that Volvo Car and Polestar are closing in on launching at least one model each but on ...
Intellego meddelade under måndagen den 19 september att bolaget ser kraftigt ökade intäkter under de...
Redeye comments on the milestone reached yesterday and the resulting movement in the share price.
XVIVO’s financial target is to reach above an EBIT margin of 20% and above EBITDA margins of 30% sup...
Redeye comments on yesterday's news regarding the CEO shift.
Mgmt. with emphasis on low churn and high uplift Confident in demand for Sign and KYC offerings Se...
Incoming CEO presented at today’s Copenhagen seminar Gas independence strengthens asset quality Po...
CEO and CFO presented at our Seminar today Focus on order-book contract mix (indexed / not indexed)...
Portföljbolagen utvecklades väl trots utmanande klimat.
Initiator Pharma announced today that the final dataset and analysis had been obtained in the IPTN20...
